Fennec Pharmaceuticals Inc

FENC NASDAQ Healthcare & Biotech United States CA31447P1009
9.77 $
1.66 %

Fennec Pharmaceuticals Inc is engaged in the development of therapeutics for the treatment of cancers in children.